I've worked every side of the table that decides whether a therapy reaches patients.

With a Master of Science from Tufts School of Engineering, I advise biopharma leaders on commercialization & corporate strategy. As co-founder and Chief Strategy & Operations Officer of BreakThru SCI, I run strategy, operations, partnerships, finance and fundraising for a national patient advocacy organization that partners with biotechs and brings their patient voice to the FDA and Congress. Before that, I co-founded Amoji, a neurotrauma health tech startup, and rose from intern to Director of Strategy &BD at a disability-tech VC.

Commercial strategy and diligence

I help biopharma leaders decide what to acquire, how to launch it and where to expand, with a focus on rare disease and CNS.

Venture and fundraising

I've sourced and diligenced 265 startups for VC funds, advised portfolio companies, and raised $175K for a growing nonprofit.

Building and operating

I founded a health tech startup with a 15-person team and run strategy, operations, finance and fundraising for a 20-person national nonprofit.

Regulatory and patient advocacy

I bring the patient voice into FDA meetings and to Congress, pushing for trial designs that measure what matters.